Table 1 Demographic characteristics, morbidity and mortality data of cardiac monitor and standard monitored patients

 Age (years)*

64.41 (56–72)

65.81 (58–72)

62.78 (52–72)

 Sex (male, n)

49 (61)

26 (61)

23 (62)

 Weight (kg)*

88.00 (75–101)

85.14 (74–96)

91.23 (75–107)

 Chronic renal failure (n)

7 (9)

4 (9)

3 (8)1

 Congestive heart failure (n)

4 (5)

3 (7)

1 (3)

 Septic shock (n)

58 (73)

32 (74)

26 (70)

 Cardiogenic shock (n)

14 (17)

6 (43)

8 (57)

 Other causes of shock/undetermined (n)

8 (10)

5 (12)

3 (8)

 MAP at time of enrolment (mmHg)

64.54 ± 6.2

64.81 ± 5.4

64.21 ± 7.1

 Bicarbonate (mmol/l)

18.63 ± 5.7

19.6 ± 4.8

18.3 ± 5.4

 Base excess (mEq/l)

− 6.89 ± 6.0

− 5.8 ± 5.9

− 7.43 ± 5.9

 Bilirubin (mol/l)*

13 (8–18)

12 (5–19)

12 (1–23)

 Haemoglobin (g/l)

111.95 ± 20.9

113.3 ± 25.1

114.1 ± 26.3

 Platelets (×10⁹/l)

214.53 ± 155.5

184.0 ± 101.3

209.2 ± 133.4

 Blood sugar level (mmol/l)

9.26 ± 4.6

8.3 ± 4

9.5 ± 5.2

 Creatinine (mol/l)*

130 (55–205)

125 (55–195)

143 (75–211)

 24-h MAP (mmHg)

72.10 ± 11.0

73.00 ± 9.8

71.25 ± 12.2

 48-h MAP (mmHg)

76.73 ± 15.0

74.64 ± 14.8

78.73 ± 15.1

 72-h MAP (mmHg)

75.29 ± 10.9

71.15 ± 8.8

79.14 ± 11.6

 Day 1 lactate (mmol/l)*

2.35

2.20

2.60

 Day 2 lactate (mmol/l)*

1.50

1.50

1.60

 Day 3 lactate (mmol/l)*

1.30

1.30

1.20

 Ventilated (n)

51 (64%)

26 (70%)

25 (58%)

 ICU stay (days)*

9.71 (5–13)

9.40 (6–12)

10.08 (6–14)

 Patients requiring dialysis (n)

17 (21)

6 (14)

11 (30)

 Death (n)

23 (29)

11 (26)

12 (32)